Salvador, E.; Köppl, T.; Hörmann, J.; Schönhärl, S.; Bugaeva, P.; Kessler, A.F.; Burek, M.; Ernestus, R.-I.; Löhr, M.; Hagemann, C.
Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics 2023, 15, 185.
https://doi.org/10.3390/pharmaceutics15010185
AMA Style
Salvador E, Köppl T, Hörmann J, Schönhärl S, Bugaeva P, Kessler AF, Burek M, Ernestus R-I, Löhr M, Hagemann C.
Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics. 2023; 15(1):185.
https://doi.org/10.3390/pharmaceutics15010185
Chicago/Turabian Style
Salvador, Ellaine, Theresa Köppl, Julia Hörmann, Sebastian Schönhärl, Polina Bugaeva, Almuth F. Kessler, Malgorzata Burek, Ralf-Ingo Ernestus, Mario Löhr, and Carsten Hagemann.
2023. "Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier" Pharmaceutics 15, no. 1: 185.
https://doi.org/10.3390/pharmaceutics15010185
APA Style
Salvador, E., Köppl, T., Hörmann, J., Schönhärl, S., Bugaeva, P., Kessler, A. F., Burek, M., Ernestus, R.-I., Löhr, M., & Hagemann, C.
(2023). Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics, 15(1), 185.
https://doi.org/10.3390/pharmaceutics15010185